Device manufacturer Onyx snapped up by Sparton for $43.25M

Onyx ($ONXX), a South Dakota manufacturer of medical devices, will soon be part of Sparton Corporation, as the industrial devicemaker has inked a deal to buy the company for $43.25 million in cash.

Onyx specializes in the contract manufacturing of medical devices and components, and the company recently expanded to Minneapolis to get closer to a hub of industry clients. Onyx churns out products for cardiovascular diagnostics, hearing assistance, point-of-care diagnostics and surgical equipment, and Sparton said the acquisition will give it a strong presence in Minneapolis' expanding medical device market.

Furthermore, Sparton's global device manufacturing capabilities will help entice more med tech clients, CEO Cary Wood said. "Onyx brings solid, long-term customer relationships that will utilize Sparton's expanded list of service offerings, such as our low-cost country footprint in Vietnam and full engineering design capabilities," Wood said in a statement.

Sparton plans to keep Onyx's management on board once the deal closes, and the corporation believes the Onyx buy will contribute about $50 million to its annual revenue.

This big bet on contract device manufacturing comes as industry giants--including Minnesota outfits such as St. Jude Medical ($STJ) and Medtronic ($MDT)--are cutting costs and trimming payroll. The resultant penny-pinching could find devicemakers scaling back their in-house manufacturing and relying instead on cost-efficient contractors, setting the stage for the bloom Sparton expects.

- here's the release

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.